Cargando…
Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
During the coronavirus disease 2019 (COVID-19) pandemic, mass vaccination was a beneficial strategy in many countries. Nevertheless, reports of serious complications such as postvaccination neuromyelitis optica spectrum disorder (NMOSD) raised concerns about the safety of vaccines. Anamnart and coll...
Autores principales: | Motahharynia, Ali, Naghavi, Saba, Shaygannejad, Vahid, Adibi, Iman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254455/ https://www.ncbi.nlm.nih.gov/pubmed/35858498 http://dx.doi.org/10.1016/j.msard.2022.104035 |
Ejemplares similares
-
Paraparesis due to aortic thromboembolism as a rare complication of COVID-19 infection
por: Motahharynia, Ali, et al.
Publicado: (2021) -
Abrupt bilateral blindness as a rare post-acute demyelinating consequence of COVID-19
por: Motahharynia, Ali, et al.
Publicado: (2022) -
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review
por: Mirmosayyeb, O., et al.
Publicado: (2023) -
Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD
por: Shi, Mingchao, et al.
Publicado: (2022) -
Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease Onset
por: Sadeghi-Bahmani, Dena, et al.
Publicado: (2022)